Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · page 13 of 23
The chart shows positive improvement for Pegzilarginase at both time points, while Placebo shows a decline at 12 weeks and slight improvement at 24 weeks.
Conference presentation · appendix_data · analyze_data · sparse density
Slide locked Sign in to view
Slide schematic 3/3
chart 1/1 table 1/1 title 1/1
Components 3
bar-grouped data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.